Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 1608
New York, New York 10022
July 11, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Tonix Pharmaceuticals Holding Corp. Registration Statement on Form S-1 (File No. 333-232195) |
Ladies and Gentlemen:
Tonix Pharmaceuticals Holding Corp. hereby requests that its acceleration request dated July 9, 2019 be withdrawn.
Please call Steven M. Skolnick of Lowenstein Sandler LLP at (973) 597-2476 with any questions.
| Very truly yours, | |||
| TONIX PHARMACEUTICALS HOLDINGS CORP. | |||
| By: | /s/Bradley Saenger | ||
| Name: | Bradley Saenger | ||
| Title: | Chief Financial Officer | ||
